Coenzyme Q10 is decreased in fibroblasts of patients with methylmalonic aciduria but not in mevalonic aciduria

Journal of Inherited Metabolic Disease

Volumn 32, Issue 4, 2009, Pages 570-575

  Haas, Dorothea ^a   Niklowitz, P ^b   Horster F ^a   Baumgartner, E R ^c   Prasad, C ^d   Rodenburg, R J ^e   Hoffmann, G F ^a   Menke, T ^b   Okun, J G ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b UNIVERSITY OF WITTEN HERDECKE   (Germany)

^c UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^d UNIVERSITY OF WESTERN ONTARIO   (Canada)

^e RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

METHYLMALONIC ACID; MEVALONIC ACID; UBIDECARENONE;

ARTICLE; CELL LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; METHYLMALONIC ACIDURIA; MEVALONIC ACIDURIA; MUSCLE LEVEL; MUSCLE TISSUE; PROTEIN CONTENT; SKIN FIBROBLAST;

CASE-CONTROL STUDIES; CELLS, CULTURED; DOWN-REGULATION; FEMALE; FIBROBLASTS; HUMANS; METABOLISM, INBORN ERRORS; METHYLMALONIC ACID; MEVALONATE KINASE DEFICIENCY; MUSCLES; UBIQUINONE;

EID: 69449083834     PISSN: 01418955     EISSN: 15732665     Source Type: Journal    
DOI: 10.1007/s10545-009-1150-8     Document Type: Article

References (34)

1. Battino M, Littarru GP, Gorini A, Villa RF (1996) Coenzyme Q, peroxidation and cytochrome oxidase features after parkinson's-like disease by MPTP toxicity in intra-synaptic and non-synaptic mitochondria from Macaca fascicularis cerebral cortex and hippocampus: Action of dihydroergocriptine. Neurochem Res 21: 1505-1514. doi: 10.1007/BF02533098
2. Brandt U, Okun JG (1997) Role of deprotonation events in ubihydroquinone:cYtochrome c oxidoreductase from bovine heart and yeast mitochondria. Biochemistry 36: 11234-11240. doi: 10.1021/bi970968g
3. Brown, MS, Goldstein, JL (1980) Multivalent feedback reulation of HMG CoA reductase, a control mechanism coordinating isoprenoid synthesis and cell growth. J Lipid Res 21: 505-517
4. Chiba K, Trevor A, Castagnoli N Jr (1984) Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidase. Biochem Biophys Res Commun 120: 574-578. doi: 10.1016/0006-291X(84)91293-2
5. Ernster L, Dallner G (1995) Biochemical, physiological and medical aspects of ubiquinone function. Biochim Biophys Acta 1271: 195-204.
6. Gibson KM, Hoffmann G, Schwall A, (1990) 3-Hydroxy-3-methylglutaryl coenzyme A reductase activity in cultured fibroblasts from patients with mevalonate kinase deficiency: Differential response to lipid supplied by fetal bovine serum in tissue culture medium. J Lipid Res 31: 515-521.
7. Gibson KM, Hoffmann GF, Tanaka RD, Bishop RW, Chambliss KL (1997) Mevalonate kinase map position 12q24. Chromosome Res 5: 150. doi: 10.1023/A:1018430527386
8. Goldstein, JL, Brown MS (1990) Regulation of the mevalonate pathway. Nature 343: 425-430. doi: 10.1038/343425a0
9. Haas D, Hoffmann GF (2007) Mevalonate kinase deficiency and autoinflammatory disorders. N Engl J Med 356: 2671-2673. doi: 10.1056/ NEJMp078083
10. Hargreaves IP (2003) Ubiquinone: Cholesterol's reclusive cousin. Ann Clin Biochem 40: 207-218. doi: 10.1258/000456303321610493
11. Helenius A, Simons K (1972) The binding of detergents to lipophilic and hydrophilic proteins. J Biol Chem 247: 3656-3661.
12. Hoffmann G, Gibson KM, Brandt IK, Bader PI, Wappner RS, Sweetman L (1986) Mevalonic aciduria - an inborn error of cholesterol and nonsterol isoprene biosynthesis. N Engl J Med 314: 1610-1614.
13. Hoffmann GF, Charpentier C, Mayatepek E, (1993) Clinical and biochemical phenotype in 11 patients with mevalonic aciduria. Pediatrics 91: 915-921.
14. Hoffmann GF, Wiesmann UN, Brendel S, Keller RK, Gibson KM (1997) Regulatory adaptation of isoprenoid biosynthesis and the LDL receptor pathway in fibroblasts from patients with mevalonate kinase deficiency. Pediatr Res 41: 541-546. doi: 10.1203/00006450-199704000-00014
15. Hörster F, Baumgartner MR, Viardot C, (2007) Long-term outcome in methylmalonic acidurias is influenced by the underlying defect (mut0, mut-, cblA, cblB). Pediatr Res 62: 225-230. doi: 10.1203/ PDR.0b013e3180a0325f
16. Hubner C, Hoffmann GF, Charpentier C, (1993) Decreased plasma ubiquinone-10 concentration in patients with mevalonate kinase deficiency. Pediatr Res 34: 129-133. doi: 10.1203/ 00006450-199308000-00004
17. Kolker S, Okun JG (2005) Methylmalonic acid-an endogenous toxin? Cell Mol Life Sci 62: 621-624. doi: 10.1007/s00018-005-4463-2
18. Kolker S, Okun JG, Horster F, (2001) 3-Ureidopropionate contributes to the neuropathology of 3-ureidopropionase deficiency and severe propionic aciduria: A hypothesis. J Neurosci Res 66: 666-673. doi: 10.1002/ jnr.10012
19. Kolker S, Schwab M, Horster F, (2003) Methylmalonic acid, a biochemical hallmark of methylmalonic acidurias but no inhibitor of mitochondrial respiratory chain. J Biol Chem 278: 47388-47393. doi: 10.1074/ jbc.M308861200
20. Ledley FD, Lumetta MR, Zoghbi HY, VanTuinen P, Ledbetter SA, Ledbetter DH (1988) Mapping of human methylmalonyl CoA mutase (MUT) locus on chromosome 6. Am J Hum Genet 42: 839-846.
21. Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265-275.
22. Mahoney MJ, Hart AC, Steen VD, Rosenberg LE (1975) Methylmalonic acidemia: Biochemical heterogeneity in defects of 5′-deoxyadenosylcobalamin synthesis. Proc Natl Acad Sci 72: 2799-2803. doi: 10.1073/pnas.72.7.2799
23. Mandey SH, Schneiders MS, Koster J, Waterham HR (2006) Mutational spectrum and genotype-phenotype correlations in mevalonate kinase deficiency. Hum Mutat 27: 796-802. doi: 10.1002/humu.20361
24. Marcoff L, Thompson PD (2007) The role of coenzyme Q10 in statin-associated myopathy: A systematic review. J Am Coll Cardiol 49: 2231-2237. doi: 10.1016/j.jacc.2007.02.049
25. 10 in plasma and erythrocytes: Comparison of antioxidant levels in healthy probands after oral supplementation and in patients suffering from sickle cell anemia. Clin Chim Acta 326: 155-161. doi: 10.1016/S0009-8981(02)00328-5
26. Niklowitz P, Menke T, Andler W, Okun JG (2004) Simultaneous analysis of coenzyme Q10 in plasma, erythrocytes and platelets: Comparison of the antioxidant level in blood cells and their environment in healthy children and after oral supplementation in adults. Clin Chim Acta 342: 219-226. doi: 10.1016/j.cccn.2003.12.020
27. Okun JG, Lummen P, Brandt U (1999) Three classes of inhibitors share a common binding domain in mitochondrial complex I (NADH: ubiquinone oxidoreductase). J Biol Chem 274: 2625-2630. doi: 10.1074/jbc.274.5.2625
28. Overvad K, Diamant B, Holm L, Holmer G, Mortensen SA, Stender S (1999) Coenzyme Q 10 in health and disease. Eur J Clin Nutr 53: 764-770. doi: 10.1038/sj.ejcn.1600880
29. Richard E, Alvarez-Barrientos A, Perez B, Desviat LR, Ugarte M (2007) Methylmalonic acidaemia leads to increased production of reactive oxygen species and induction of apoptosis through the mitochondrial/caspase pathway. J Pathol 213: 453-461. doi: 10.1002/path.2248
30. Schwab MA, Sauer SW, Okun JG, (2006) Secondary mitochondrial dysfunction in propionic aciduria: A pathogenic role for endogenous mitochondrial toxins. Biochem J 398: 107-112. doi: 10.1042/BJ20060221
31. 9 levels in mouse tissues by HPLC with coulometric detection. Clin Chim Acta 341: 173-184. doi: 10.1016/j.cccn.2003.12.002
32. Wanders RJ, Vreken P, den Boer ME, Wijburg FA, van Gennip AH, IJlst L (1999) Disorders of mitochondrial fatty acyl-CoA beta-oxidation. J Inherit Metab Dis 22: 442-487. doi: 10.1023/A:1005504223140
33. Weber C, Bysted A, Hllmer G (1997) The coenzyme Q10 content of the average Danish diet. Int J Vitam Nutr Res 67: 123-129.
34. Zhang Y, Aberg F, Appelkvist EL, Dallner G, Ernster L (1995) Uptake of dietary coenzyme Q supplement is limited in rats. J Nutr 125: 446-453.